argenx SE (ARGX) stock

ARGXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 19, 2026Score 5/30

$960.04−21.29 (-2.17%)

Close on Nov 13, 2026Market cap –P/E 49.1Yield –

argenx EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

argenx's EV/EBITDA was 54.6× on Nov 11, 2026.

Period	Period end	Value	Change (pts)
2026	Nov 11, 2026	54.6×	–

See a number that looks wrong?